Green-lipped Mussel (Perna canaliculus) safely helps dogs with arthritis
September
15,
2009
Researchers at the Faculty of
Veterinary Medicine, Department of
Equine and Small Animal Medicine, University of Helsinki in Finland
evaluated Perna green-lipped mussel (GLM) preparation in a randomized,
double-controlled and double-blinded clinical trial. It was
hypothesized that the treatment effect would be less than that of the
positive control with the powerful drug Rimadyl (carprofen) but more
than that of the sham treatment (placebo); Rimadyl has to be monitored
because it causes severe liver damage and death in some breeds.
Forty-five dogs with chronic pain and a radiographic diagnosis of
osteoarthritis that were randomly allocated into one of three groups
completed the study. All dogs were fed the test products or placebo for
8 weeks. The dogs were evaluated four times, at 4-week intervals.
Intake of extra carprofen was also evaluated. When changed to
dichotomous variables, there were more dogs in the GLM than in the
placebo group that improved, according to veterinary-assessed mobility,
owner-evaluated chronic pain index and pain. The extent of improvement
was significantly different between the GLM and the control in
veterinary-assessed mobility and pain VAS (a scale from 1 to 10
describing the level of pain). In conclusion, GLM alleviated chronic
orthopedic pain in dogs although it was not as effective as carprofen.
As no side-effects were detected, GLM may be beneficial in dogs e.g.
when non-steroidal anti-inflammatory drugs cannot be used. The study is
published in the September 2009 issue of the journal Evidence
Based
Complementary and Alternative Medicine.